Insights | CRB

Lab design techniques to accelerate COVID test processing

Testing is a crucial component of our global response to COVID-19. The more people we can test for the virus, the better we can understand the threat we’re up against.

COVID-19: 7 Steps to plan for re-entering the workplace

The COVID-19 pandemic has presented new challenges and created questions about what life in the office will look like going forward.

The basics and the process of drug approval

The COVID-19 pandemic has put the spotlight on the FDA drug approval process. Why will it take so long for a vaccine to get approved?

During a crisis, moving drugs to market requires a strong HVAC strategy

As the global pandemic brings new attention to emerging therapies, the biopharmaceutical industry shouldn’t overlook HVAC design for contamination control.

6 considerations for scaling up an industrial biotechnology process

Industrial biotechnology processes face a unique set of challenges when it comes to scale-up.

Preventing the next pandemic: mRNA vaccines and siRNA oligo therapies

Investing in promising new pharmaceutical platforms like oligonucleotide therapies could reduce the gap between first detection and total eradication in future pandemics.

4 strategies of successful project execution

A lean approach to project execution relies on four steps for success.

Developing new tools in the pandemic response toolbox

There’s a lot to be learned from the COVID-19 pandemic, including how we can be better prepared for future pandemics.

Viral vectors—beyond the yellow brick road

The science of viral vector manufacturing is generating a lot of excitement, and companies in this space are under pressure to move fast and make cost-effective decisions; this can occasionally result in speed at the expense of due diligence.